Literature DB >> 23282130

Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Lisa M Manus1, Robert J Holbrook, Tulay A Atesin, Marie C Heffern, Allison S Harney, Amanda L Eckermann, Thomas J Meade.   

Abstract

The kinetic and thermodynamic ligand exchange dynamics are important considerations in the rational design of metal-based therapeutics and therefore, require detailed investigation. Co(III) Schiff base complex derivatives of bis(acetylacetone)ethylenediimine [acacen] have been found to be potent enzyme and transcription factor inhibitors. These complexes undergo solution exchange of labile axial ligands. Upon dissociation, Co(III) irreversibly interacts with specific histidine residues of a protein, and consequently alters structure and causes inhibition. To guide the rational design of next generation agents, understanding the mechanism and dynamics of the ligand exchange process is essential. To investigate the lability, pH stability, and axial ligand exchange of these complexes in the absence of proteins, the pD- and temperature-dependent axial ligand substitution dynamics of a series of N-heterocyclic [Co(acacen)(X)(2)](+) complexes [where X = 2-methylimidazole (2MeIm), 4-methylimidazole (4MeIm), ammine (NH(3)), N-methylimidazole (NMeIm), and pyridine (Py)] were characterized by NMR spectroscopy. The pD stability was shown to be closely related to the nature of the axial ligand with the following trend toward aquation: 2MeIm > NH(3) ≫ 4MeIm > Py > Im > NMeIm. Reaction of each [Co(III)(acacen)(X)(2)](+) derivative with 4MeIm showed formation of a mixed ligand Co(III) intermediate via a dissociative ligand exchange mechanism. The stability of the mixed ligand adduct was directly correlated to the pD-dependent stability of the starting Co(III) Schiff base with respect to [Co(acacen)(4MeIm)(2)](+). Crystal structure analysis of the [Co(acacen)(X)(2)](+) derivatives confirmed the trends in stability observed by NMR spectroscopy. Bond distances between the Co(III) and the axial nitrogen atoms were longest in the 2MeIm derivative as a result of distortion in the planar tetradentate ligand, and this was directly correlated to axial ligand lability and propensity toward exchange.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23282130      PMCID: PMC3554264          DOI: 10.1021/ic302379j

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  23 in total

1.  Medicinal inorganic chemistry: introduction.

Authors:  C Orvig; M J Abrams
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Design of targeting ligands in medicinal inorganic chemistry.

Authors:  Tim Storr; Katherine H Thompson; Chris Orvig
Journal:  Chem Soc Rev       Date:  2006-04-20       Impact factor: 54.564

3.  Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate.

Authors:  Ryan R Hurtado; Allison S Harney; Marie C Heffern; Robert J Holbrook; Robert A Holmgren; Thomas J Meade
Journal:  Mol Pharm       Date:  2012-01-20       Impact factor: 4.939

4.  Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.

Authors:  T Takeuchi; A Böttcher; C M Quezada; T J Meade; H B Gray
Journal:  Bioorg Med Chem       Date:  1999-05       Impact factor: 3.641

5.  Towards Antitumor Active trans-Platinum Compounds.

Authors:  Sheena M Aris; Nicholas P Farrell
Journal:  Eur J Inorg Chem       Date:  2009-04-01       Impact factor: 2.524

Review 6.  Boon and bane of metal ions in medicine.

Authors:  Katherine H Thompson; Chris Orvig
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

Review 7.  New metal complexes as potential therapeutics.

Authors:  Christiana Xin Zhang; Stephen J Lippard
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  A cobalt complex that selectively disrupts the structure and function of zinc fingers.

Authors:  A Y Louie; T J Meade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Isolation of a myoglobin molten globule by selective cobalt(III)-induced unfolding.

Authors:  O Blum; A Haiek; D Cwikel; Z Dori; T J Meade; H B Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 10.  New trends for metal complexes with anticancer activity.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Curr Opin Chem Biol       Date:  2008-01-25       Impact factor: 8.822

View more
  9 in total

1.  Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Josh W Kurutz; Thomas J Meade
Journal:  Chemistry       Date:  2013-11-06       Impact factor: 5.236

2.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

3.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

4.  Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Pauline T Velasco; Lauren M Matosziuk; Joseph L Coomes; Constantine Karras; Mark A Ratner; William L Klein; Amanda L Eckermann; Thomas J Meade
Journal:  Chembiochem       Date:  2014-06-24       Impact factor: 3.164

5.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

6.  Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.

Authors:  Marie C Heffern; Viktorie Reichova; Joseph L Coomes; Allison S Harney; Elizabeth A Bajema; Thomas J Meade
Journal:  Inorg Chem       Date:  2015-09-02       Impact factor: 5.165

7.  Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate.

Authors:  Luke F Vistain; Natsuho Yamamoto; Richa Rathore; Peter Cha; Thomas J Meade
Journal:  Chembiochem       Date:  2015-08-25       Impact factor: 3.164

8.  Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.

Authors:  Mark D Peterson; Robert J Holbrook; Thomas J Meade; Emily A Weiss
Journal:  J Am Chem Soc       Date:  2013-08-23       Impact factor: 15.419

9.  Nontoxic Cobalt(III) Schiff Base Complexes with Broad-Spectrum Antifungal Activity.

Authors:  Angelo Frei; A Paden King; Gabrielle J Lowe; Amy K Cain; Francesca L Short; Hue Dinh; Alysha G Elliott; Johannes Zuegg; Justin J Wilson; Mark A T Blaskovich
Journal:  Chemistry       Date:  2020-11-24       Impact factor: 5.020

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.